Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Apr. 02, 2016		Mar. 28, 2015
Operating activities:
Net income	$ 1,900,501		$ 1,743,763
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	$ 586,422		606,079
Provision for losses on accounts receivable			23,057
Loss (gain) on sale of equipment and patents	$ 7,658		(46,751)
Increase in cash value of life insurance	(79,715)		(83,142)
Deferred compensation	$ (42,769)		(40,758)
Stock compensation expense			13,318
Changes in operating assets and liabilities:
Accounts receivable	$ 1,342,115		(2,306,004)
Inventories	1,024,721		1,396,734
Prepaid expenses and other assets	(237,074)		(293,976)
Accounts payable and accrued expenses	(2,591,084)		763,037
Net cash provided by operating activities	1,910,775		1,775,357
Investing activities:
Purchases of property and equipment	$ (275,384)		(140,576)
Proceeds from sale of equipment and patents			47,339
Payments for other assets	$ (57,067)		(52,729)
Net cash used for investing activities	(332,451)		(145,966)
Financing activities:
Dividends paid	(873,590)		$ (3,853,712)
Proceeds of revolving credit line	2,900,000
Repayment of revolving credit line	$ (2,900,000)
Common stock issued upon exercise of options			$ 180,708
Purchase and retirement of common stock	$ (209,880)
Net cash used for financing activities	(1,083,470)		$ (3,673,004)
Effect of exchange rates on cash	14,500		(63,830)
Increase (decrease) in cash and cash equivalents	509,354		(2,107,443)
Cash and cash equivalents at beginning of period	1,224,026	[1]	6,865,931
Cash and cash equivalents at end of period	$ 1,733,380		$ 4,758,488

[1] The Balance Sheet at October 3, 2015, has been derived from the audited financial statements at that date.